Portal de Periódicos da CAPES

The MIS-COVID-AGICT Study: Trend of Minimally Invasive Surgery for Gastrointestinal Cancer Treatment During the First Waves of the COVID-19 Pandemic in Italy. Subgroup Analysis from the COVID-AGICT Study: COVID-19 and Advanced Gastrointestinal Cancer Surgical Treatment

2023; Mary Ann Liebert, Inc.; Volume: 33; Issue: 6 Linguagem: Inglês

10.1089/lap.2023.0058

1557-9034

Giuseppe Giuliani, Diego Coletta, Francesco Guerra, Sofia Esposito, Alessandro Esposito, Matteo De Pastena, Daniela Rega, Paolo Delrio, Carlotta La Raja, Antonino Spinelli, Simonetta Massaron, Paola De Nardi, Emanuele F. Kauffmann, Ugo Boggi, Simona Deidda, Luigi Zorcolo, Alessandra Marano, Felice Borghi, Micaela Piccoli, Norma Depalma, Stefano D’Ugo, Marcello Spampinato, Federico Cozzani, Paolo Del Rio, Rosa Marcellinaro, Massimo Carlini, Raffaele De Rosa, Stefano Scabini, Fabio Maiello, Roberto Polastri, Giulia Turri, Corrado Pedrazzani, Monica Zese, Dario Parini, Andrea Coratti, Lucia Salvischiani, Francesco Santelli, Angelo Restivo, Andrea Casaril, Gianluigi Moretto, Antonio De Leo, Marco Catarci, Renza Trapani, Sandro Zonta, Patrizia Marsanic, Andrea Muratore, Gregorio Di Franco, Luca Morelli, Alessandro Coppola, Damiano Caputo, Jacopo Andreuccetti, Giusto Pignata, Laura Mastrangelo, Elio Jovine, Michele Mazzola, Giovanni Ferrari, Lorenzo Mariani, Graziano Ceccarelli, Rocco Giuseppe, Stefano Bolzon, Mariateresa Grasso, Silvio Testa, Paola Germani, Nicolò de Manzini, Serena Langella, Alessandro Ferrero, Alfredo Genovese, Dario Sirimarco, Angela Tribuzi, Martina Maruccio, Federico Faustini, Giorgio Lisi, Fabrizio Allisiardi, Michele Grieco, C. Righetti, Marco Frisini, Alberto Brolese, Michele Grassia, Andrea Lucchi, Giulia Bagaglini, Giuseppe Sica, Michele Manara, Luca Turati, Lorenzo Macone, Roberta Carminati, Pierpaolo Mariani, Gianluca Rizzo, Claudio Coco, Francesca Pennetti Pennella, Fabio Rondelli, Lucia Romano, Antonio Giuliani, Raffaéle Palaia, Andrea Belli, Vittorio Albino, Maddalena Leongito, Giulia David, Pasquale Misitano, Silvia Pasulo, Gian Luca Baiocchi, Roberta La Mendola, Mohamnad Abu Hilal, Ludovica Baldari, Elisa Cassinotti, Luigi Boni, Gabriella Teresa Capolupo, Marco Caricato, Enrico Pinotti, Mauro Montuori, Cristina Bombardini, Gabriele Anania, Rigers Dibra, Gennaro Martines, Leonardo Solaini, Giorgio Ercolani, Renato Oliva, Maria Vittoria Carati, Gian Luca Grazi, Giacomo Ghio, Francesco Marchegiani, Salvatore Pucciarelli, Filippo La Torre, Immacolata Iannone, Dimitri Krizzuk, Francesco Sammartino, Nicola Cillara, Antonello Deserra, Alessandro Cannavera, Giorgia Catalano, Paolo Strignano, Renato Romagnoli, Domenico Piccione, Bruno Nardo, Rossella Reddavid, Maurizio Degiuli, Martino Gerosa, Dario Maggioni, Michele Zuolo, Marco Rigamonti, Omar Ghazouani, Raffaele Galleano, Andrea Percivale, Luca Tirloni, Luca Moraldi, Nicolò Fabbri, Carlo V. Feo, S Colombo, Salomone Di Saverio, Giuseppe Barbato, Francesco Coratti, Andrea Sagnotta, Stefano Mancini, Luca Ferraro, Giampaolo Formisano, Paolo Pietro Bianchi, Simona Messinese, Carmelo Bengala, Michele Di Marino,

Pancreatic and Hepatic Oncology Research

Background: A preliminary analysis from the COVID-Advanced Gastrointestinal Cancer Surgical Treatment (AGICT) study showed that the rate of minimally invasive surgery (MIS) for elective and urgent procedures did not decrease during the pandemic year. In this article, we aimed to perform a subgroup analysis using data from the COVID-AGICT study to evaluate the trend of MIS during the COVID-19 pandemic period in Italy. Methods: This study was conducted collecting data of MIS patients from the COVID-AGICT database. The primary endpoint was to demonstrate whether the SARS-CoV-2 pandemic scenario reduced MIS for elective treatment of gastrointestinal cancer (GIC) in Italy in 2020. The secondary endpoint was to evaluate the impact of the pandemic period on perioperative outcomes in the MIS group. Results: In the pandemic year, 62% of patients underwent surgery with a minimally invasive approach, compared to 63% in 2019 (P = .23). In 2020, the proportion of patients undergoing elective MIS decreased compared to the previous year (80% versus 82%, P = .04), and the rate of urgent MIS did not differ between the 2 years (31% and 33% in 2019 and 2020 - P = .66). Colorectal cancer was less likely to be treated with MIS approach during 2020 (78% versus 75%, P < .001). Conversely, the rate of MIS pancreatic resection was higher in 2020 (28% versus 22%, P < .002). Conversion to an open approach was lower in 2020 (7.2% versus 9.2% - P = .01). Major postoperative complications were similar in both years (11% versus 11%, P = .9). Conclusion: In conclusion, although MIS for elective treatment of GIC in Italy was reduced during the COVID-19 pandemic period, our study revealed that the overall proportion of MIS (elective and urgent) and postoperative outcomes were comparable to the prepandemic period. ClinicalTrial.gov (NCT04686747).